Since inhibition of CDK9 activity is being explored as a therapeutic avenue in a number of diseases including AIDS, cancer, cardiac myopathies and inflammatory processes [11,18-20], it is important to examine the time dependent consequences of CDK9 inhibition on gene expression. This evidence concerns the gene CDK9 and cancer.